Oral Dexmedetomidine vs Midazoam For Premedication

Premedication Clinical Trial

Official title: Oral Dexmedetomidine vs Midazoam For Premedication And Emergence Delirium in Children Undergoing Dental Treatment

Status Completed

Clinical Trial Summary

The aim of this study was to compare the effect of 2 µg/kg of oral dexmedetomidine (DEX) and 0.5 mg/kg dormicum as premedication among children undergoing dental procedures.

Clinical Trial Description

The study involved 52 children between 3-7 years of age, ASA I , who underwent full-mouth dental rehabilitation. The DEX group (n=26) received 2 µg/kg DEX in apple juice, and the control group (n=26) received 0.5 mg/kg midazolam in apple juice.

The patients' scores on the Ramsey sedation scale (RSS), parental separation anxiety scale, mask acceptance scale, post-anesthesia emergence delirium scale (PAEDS), and hemodynamic parameters were recorded. The data were analyzed using chi-square test, Fisher's exact test, student t test, and analysis of variance in SPSS. ;

Related Conditions & MeSH terms

• Premedication

• NCT number: NCT03357718
• Study type: Interventional
• Source: Aydin Adnan Menderes University
• Status: Completed
• Phase: Phase 4
• Start date: November 1, 2016
• Completion date: June 1, 2017